Research output per year
Research output per year
Fingerprint
Dive into the research topics where Giuseppe Fasolino is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors and immune checkpoint inhibitors
Awada, G., Schwarze, J. K., Tijtgat, J., Fasolino, G., Kruse, V. & Neyns, B., 1 Jun 2022, In: Melanoma Research. 32, 3, p. 183-191 9 p.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Choroidal and Choriocapillaris Morphology in Pan-FGFR Inhibitor-Associated Retinopathy: A Case Report
Fasolino, G., Nelis, P. J., Ten Tusscher, M., Moschetta, L., De Grève, J. & Lefesvre, P., 20 Jan 2022, In: Diagnostics (Basel, Switzerland). 2022, 12, p. 1-7 7 p., 249.Research output: Contribution to journal › Article › peer-review
Open Access -
Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report
Lambert, I., Fasolino, G., Awada, G., Kuijpers, R., Ten Tusscher, M. & Neyns, B., 5 Jun 2021, In: BMC ophtalmol. 21, 1, 8 p., 250.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRASQ61R/K/L Mutant Melanoma (TraMel-WT)
Awada, G., Schwarze, J. K., Tijtgat, J., Fasolino, G., Everaert, H. & Neyns, B., 1 May 2021, In: Cancers (Basel). 13, 9, 13 p., 2010.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)94 Downloads (Pure) -
A phase 2 clinical trial on trametinib and low-dose dabrafenib in advanced pretreated BRAF(V600)/NRAS(Q61R/K/L) wild-type melanoma (TraMel-WT): Interim efficacy and safety results.
Awada, G., Schwarze, J. K., Tijtgat, J., Fasolino, G., Everaert, H. & Neyns, B., 20 May 2021, In: Journal of Clinical Oncology. 39, 15, 9529.Research output: Contribution to journal › Meeting abstract (Journal)
Open Access
Activities
-
ocular toxicity related to new oncological treatment
Giuseppe Fasolino (Speaker)
19 Jun 2021Activity: Talk or presentation › Talk or presentation at a conference
-
Manama Meeting UZBrussel
Pieter Jan Nelis (Chair) & Giuseppe Fasolino (Chair)
19 Jun 2021Activity: Participating in or organising an event › Participating in or organizing an event at an external academic organisation
-
Manama Meeting UZBrussel
Giuseppe Fasolino (Chair)
19 Jun 2021Activity: Participating in or organising an event › Participation in conference
-
brussel retina meeting
Giuseppe Fasolino (Chair)
4 Apr 2019 → 6 Apr 2019Activity: Participating in or organising an event › Participating in or organizing an event at an external academic organisation
-
subtreshold laser treatment in diabetic retinopathy
Giuseppe Fasolino (Speaker)
7 Sep 2019Activity: Talk or presentation › Talk or presentation at a conference